Role of PI3K, MAPK/ERK1/2, and p38 in Implementation of the Proliferative and Differentiation Potential of Erythroid Progenitors after Blood Loss

Verfasser / Beitragende:
[A. Dygai, V. Zhdanov, L. Miroshnichenko, E. Udut, G. Zyuz'kov, E. Simanina, E. Sherstoboev, A. Chaikovskii, L. Stavrova, Ya. Burmina, T. Khrichkova, D. Reichart, V. Goldberg]
Ort, Verlag, Jahr:
2015
Enthalten in:
Bulletin of Experimental Biology and Medicine, 158/4(2015-02-01), 417-420
Format:
Artikel (online)
ID: 605538158
LEADER caa a22 4500
001 605538158
003 CHVBK
005 20210128100900.0
007 cr unu---uuuuu
008 210128e20150201xx s 000 0 eng
024 7 0 |a 10.1007/s10517-015-2775-2  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10517-015-2775-2 
245 0 0 |a Role of PI3K, MAPK/ERK1/2, and p38 in Implementation of the Proliferative and Differentiation Potential of Erythroid Progenitors after Blood Loss  |h [Elektronische Daten]  |c [A. Dygai, V. Zhdanov, L. Miroshnichenko, E. Udut, G. Zyuz'kov, E. Simanina, E. Sherstoboev, A. Chaikovskii, L. Stavrova, Ya. Burmina, T. Khrichkova, D. Reichart, V. Goldberg] 
520 3 |a The involvement of PI3K, ERK and p38-dependent signaling system in the regulation of functional activity of erythroid precursors after blood loss (30% of circulating volume) was studied. We demonstrated the important role of PI3K and p38 in the suppression of differentiation of erythroid precursors the contribution of p38 to stimulation of mitotic activity of erythroid CFU, which maintains the growth potential of the precursors at the optimal physiological level. The classical MAPK/ERK-kinase pathway does not determine the proliferative and differentiation status of erythroid CFU. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a PI3K  |2 nationallicence 
690 7 |a MAPK/ERK1/2  |2 nationallicence 
690 7 |a p38, erythroid precursors  |2 nationallicence 
690 7 |a blood loss  |2 nationallicence 
700 1 |a Dygai  |D A.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
700 1 |a Zhdanov  |D V.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
700 1 |a Miroshnichenko  |D L.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
700 1 |a Udut  |D E.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
700 1 |a Zyuz'kov  |D G.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
700 1 |a Simanina  |D E.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
700 1 |a Sherstoboev  |D E.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
700 1 |a Chaikovskii  |D A.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
700 1 |a Stavrova  |D L.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
700 1 |a Burmina  |D Ya  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
700 1 |a Khrichkova  |D T.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
700 1 |a Reichart  |D D.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
700 1 |a Goldberg  |D V.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
773 0 |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 158/4(2015-02-01), 417-420  |x 0007-4888  |q 158:4<417  |1 2015  |2 158  |o 10517 
856 4 0 |u https://doi.org/10.1007/s10517-015-2775-2  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10517-015-2775-2  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Dygai  |D A.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Zhdanov  |D V.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Miroshnichenko  |D L.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Udut  |D E.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Zyuz'kov  |D G.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Simanina  |D E.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Sherstoboev  |D E.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Chaikovskii  |D A.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Stavrova  |D L.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Burmina  |D Ya  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Khrichkova  |D T.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Reichart  |D D.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Goldberg  |D V.  |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 158/4(2015-02-01), 417-420  |x 0007-4888  |q 158:4<417  |1 2015  |2 158  |o 10517